80 FR 41048 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 134 (July 14, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 134 (July 14, 2015)
| Page Range | 41048-41048 | |
| FR Document | 2015-17160 |
[Federal Register Volume 80, Number 134 (Tuesday, July 14, 2015)] [Notices] [Page 41048] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-17160] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implantation Grant (R01). Date: August 17, 2015. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: 5061 Fishers Lane, Conference Room 3F100, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Paul Roberts, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G22, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Rockville, MD 20852, 240-669-5053, [email protected]. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implantation Grant (R01). Date: August 18, 2015. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: 5601 Fishers Lane, Conference Room 3F100, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Paul Roberts, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G22, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Rockville, MD 20852, 240-669-5053, [email protected]. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implantation Cooperative Agreement (U01). Date: August 19, 2015. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: 5601 Fishers Lane, Conference Room 3F100, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Paul Roberts, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G22, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Rockville, MD 20852, 240-669-5053, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: July 8, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015-17160 Filed 7-13-15; 8:45 am] BILLING CODE 4140-01-P
![41048 Federal Register / Vol. 80, No. 134 / Tuesday, July 14, 2015 / Notices
topic. At least 7 minutes will be allotted limitations of new, revised, and Name of Committee: National Institute of
for each speaker, and if time permits, alternative test methods and strategies. Allergy and Infectious Diseases Special
may be extended up to 10 minutes at the NICEATM and ICCVAM work Emphasis Panel; NIAID Clinical Trial
discretion of the chair. Registration for collaboratively to evaluate new and Implantation Grant (R01).
oral comments will also be available on- improved test methods and strategies Date: August 17, 2015.
site, although time allowed for applicable to the needs of U.S. federal Time: 2:00 p.m. to 4:00 p.m.
presentation by on-site registrants may agencies. NICEATM and ICCVAM Agenda: To review and evaluate grant
be less than for registered speakers and welcome the public nomination of new, applications.
will be determined by the number of revised, and alternative test methods Place: 5061 Fishers Lane, Conference
persons who register at the meeting. In and strategies for validation studies and Room 3F100, Rockville, MD 20852,
addition to in-person oral comments at technical evaluations. Additional (Telephone Conference Call).
the meeting, public comments can be information about ICCVAM and Contact Person: Paul Roberts, Ph.D.,
presented by teleconference line. There NICEATM can be found at http:// Scientific Review Officer, Scientific Review
will be 50 lines for this call; availability ntp.niehs.nih.gov/go/iccvam and http:// Program, Division of Extramural Activities,
will be on a first-come, first-served ntp.niehs.nih.gov/go/niceatm. Room 3G22, National Institutes of Health/
basis. The lines will be open from 8:30 SACATM was established in response NIAID, 5601 Fishers Lane, MSC 9823,
a.m. until approximately 5:00 p.m., to the ICCVAM Authorization Act Rockville, MD 20852, 240–669–5053,
although public comments will be [Section 285l–3(d)] and is composed of paul.roberts@nih.gov.
received only during the formal public scientists from the public and private Name of Committee: National Institute of
comment periods, which will be sectors. SACATM advises ICCVAM, Allergy and Infectious Diseases Special
indicated on the preliminary agenda. NICEATM, and the Director of the Emphasis Panel; NIAID Clinical Trial
The access number for the NIEHS and NTP regarding statutorily Implantation Grant (R01).
teleconference line will be provided to mandated duties of ICCVAM and Date: August 18, 2015.
registrants by email prior to the meeting. activities of NICEATM. SACATM Time: 2:00 p.m. to 4:00 p.m.
Persons wishing to present oral provides advice on priorities and Agenda: To review and evaluate grant
comments are encouraged to register activities related to the development, applications.
using the SACATM meeting registration validation, scientific review, regulatory Place: 5601 Fishers Lane, Conference
form (http://ntp.niehs.nih.gov/go/ acceptance, implementation, and Room 3F100, Rockville, MD 20852,
32822), indicate the topic(s) on which national and international (Telephone Conference Call).
they plan to comment, and, if possible, harmonization of new, revised, and Contact Person: Paul Roberts, Ph.D.,
send a copy of their statement to alternative toxicological test methods. Scientific Review Officer, Scientific Review
whiteld@niehs.nih.gov by August 26, Additional information about SACATM, Program, Division of Extramural Activities,
2015, to enable review by SACATM, including the charter, roster, and Room 3G22, National Institutes of Health/
NICEATM, ICCVAM, and NIEHS/NTP records of past meetings, can be found NIAID, 5601 Fishers Lane, MSC 9823,
staff prior to the meeting. Written at http://ntp.niehs.nih.gov/go/167. Rockville, MD 20852, 240–669–5053,
statements can supplement and may paul.roberts@nih.gov.
Dated: July 8, 2015.
expand the oral presentation. If Name of Committee: National Institute of
John R. Bucher,
registering on-site and reading from Allergy and Infectious Diseases Special
Associate Director, National Toxicology
written text, please bring 20 copies of Emphasis Panel; NIAID Clinical Trial
Program.
the statement for distribution and to Implantation Cooperative Agreement (U01).
[FR Doc. 2015–17165 Filed 7–13–15; 8:45 am]
supplement the record. Date: August 19, 2015.
Background Information on ICCVAM, BILLING CODE 4140–01–P Time: 2:00 p.m. to 4:00 p.m.
NICEATM, and SACATM: ICCVAM is Agenda: To review and evaluate grant
an interagency committee composed of applications.
representatives from 15 federal DEPARTMENT OF HEALTH AND Place: 5601 Fishers Lane, Conference
regulatory and research agencies that HUMAN SERVICES Room 3F100, Rockville, MD 20852,
require, use, generate, or disseminate National Institutes of Health (Telephone Conference Call).
toxicological and safety testing Contact Person: Paul Roberts, Ph.D.,
information. ICCVAM conducts National Institute of Allergy and Scientific Review Officer, Scientific Review
technical evaluations of new, revised, Infectious Diseases; Notice of Closed Program, Division of Extramural Activities,
and alternative safety testing methods Meetings Room 3G22, National Institutes of Health/
with regulatory applicability and NIAID, 5601 Fishers Lane, MSC 9823,
promotes the scientific validation and Pursuant to section 10(d) of the Rockville, MD 20852, 240–669–5053,
regulatory acceptance of toxicological Federal Advisory Committee Act, as paul.roberts@nih.gov.
and safety-testing methods that more amended (5 U.S.C. App.), notice is (Catalogue of Federal Domestic Assistance
accurately assess the safety and hazards hereby given of the following meetings. Program Nos. 93.855, Allergy, Immunology,
of chemicals and products and that The meetings will be closed to the and Transplantation Research; 93.856,
reduce, refine (decrease or eliminate public in accordance with the Microbiology and Infectious Diseases
pain and distress), or replace animal provisions set forth in sections Research, National Institutes of Health, HHS)
use. The ICCVAM Authorization Act of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Dated: July 8, 2015.
2000 (42 U.S.C. 285l–3) established as amended. The grant applications and
asabaliauskas on DSK5VPTVN1PROD with NOTICES
ICCVAM as a permanent interagency the discussions could disclose David Clary,
committee of the NIEHS under confidential trade secrets or commercial Program Analyst, Office of Federal Advisory
NICEATM. property such as patentable material, Committee Policy.
NICEATM administers ICCVAM, and personal information concerning [FR Doc. 2015–17160 Filed 7–13–15; 8:45 am]
provides scientific and operational individuals associated with the grant BILLING CODE 4140–01–P
support for ICCVAM-related activities, applications, the disclosure of which
and conducts independent validation would constitute a clearly unwarranted
studies to assess the usefulness and invasion of personal privacy.
VerDate Sep<11>2014 19:09 Jul 13, 2015 Jkt 235001 PO 00000 Frm 00058 Fmt 4703 Sfmt 9990 E:\FR\FM\14JYN1.SGM 14JYN1](https://thefederalregister.org/doc/80_FR_41182/page/1.svg)
Document Created: 2018-02-23 09:19:52
Document Modified: 2018-02-23 09:19:52
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | August 17, 2015. | |
| FR Citation | 80 FR 41048 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR